Tumefactive demyelinating lesion during B-cell depletion therapy by ofatumumab. Shinoda K, Masaki K, Matsuyoshi A, Kira YI, et al. Mult Scler 2026;32:244-247.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shinoda K, Masaki K, Matsuyoshi A, Kira YI, et al. Tumefactive demyelinating lesion during B-cell depletion therapy by ofatumumab. Mult Scler 2026;32:244-247.
PMID: 41024463